Drug
Resiniferatoxin clinical trials
Keep track of what changes. Save the resiniferatoxin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 4
Sorrento Therapeutics, Inc. (7) · National Institutes of Health Clinical Center (CC) (1) · Grünenthal GmbH (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · Medical University of Vienna (1)
Studies
Open first, then newest update. How each study uses resiniferatoxin is read from its arms, and is right about nine times in ten.
Testing it · 12
- Resiniferatoxin to Treat Severe Pain Associated With Advanced CancerRecruitingPhase 1National Institute of Dental and Craniofacial Research (NIDCR)NCT00804154Written as Intrathecal Resiniferatoxin
- Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone PainNot yet recruitingPhase 1/2National Institute of Neurological Disorders and Stroke (NINDS)NCT02522611Written as Resiniferatoxin
- Resiniferatoxin for the Management of Refractory Morton s Neuroma PainCompletedPhase 1National Institutes of Health Clinical Center (CC)NCT05695339Written as Resiniferatoxin
- Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced CancerSuspendedPhase 2Sorrento Therapeutics, Inc.NCT05067257Written as Resiniferatoxin
- Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee OsteoarthritisStatus unknownPhase 2Sorrento Therapeutics, Inc.NCT04885972Written as Resiniferatoxin
- Non-inferiority of Reduced-dose Rituximab in Rheumatoid Arthritis in Low Disease Activity and RemissionTerminatedPhase 4Medical University of ViennaNCT05116228Written as 500mg RTX Group
- Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer PainWithdrawnPhase 3Sorrento Therapeutics, Inc.NCT04572776Written as Resiniferatoxin
- Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is DelayedWithdrawnPhase 3Sorrento Therapeutics, Inc.NCT04386980Written as Resiniferatoxin
- A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the KneeWithdrawnPhase 3Sorrento Therapeutics, Inc.NCT04044742Written as Resiniferatoxin
- Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint PainCompletedPhase 1Grünenthal GmbHNCT02566564Written as Lopain
- Study of Resiniferatoxin for Knee Pain in Moderate to Severe OsteoarthritisCompletedPhase 1Sorrento Therapeutics, Inc.NCT03542838Written as Resiniferatoxin
- Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer PainCompletedPhase 1Sorrento Therapeutics, Inc.NCT03226574Written as Resiniferatoxin
Codes
What other systems call resiniferatoxin · ClinicalTrials.gg INT002788
- MeSH (NLM) C024353resiniferatoxinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) A5O6P1UL4IRESINIFERATOXINConfirmed FDA, NLM, Wikidata
- Wikidata Q3277888resiniferatoxinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1214ResiniferatoxinOne source FDA
- DrugBank DB06515One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C024353 | resiniferatoxin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | A5O6P1UL4I | RESINIFERATOXIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3277888 | resiniferatoxin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1214 | Resiniferatoxin | One source FDA |
| DrugBank | DB06515 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.